This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
The next wave came from early research into liposomes and lipid nanoparticles, both of which are used for drugdelivery. Liposomes have the same function as lipid nanoparticles in drugdelivery but have a simpler formulation. Lipid nanoparticle drugdelivery was in the spotlight during the Covid-19 pandemic.
A team of scientists from the universities of Glasgow and Tel Aviv has developed a groundbreaking method to transform the brain parasite Toxoplasma gondii into a potential vehicle for delivering therapeutic treatments directly to brain cells.
Highlights include expansion of biotech operations in Philadelphia, acquisition of a new pharma-device facility near Dublin, Ireland, and a new Center of Excellence for advanced drugdelivery and drug-device combination product assembly in Rockford, Illinois.
Four faculty members in the University of Arizona College of Engineering have received CAREER Awards from the National Science Foundation. Their work ranges from improving drugdelivery for disease and managing renewable energy to advancing quantum technology.
DrugDelivery Devices Symposium. We have the distinct privilege of unveiling Oxford Global’s DrugDelivery Devices Symposium, taking place on the 10th of March, 2021. Discuss Combination Product Development & Engineering with leading experts such as Andrew Yum , United Therapeutics and Ning Yu , Biogen.
Texas A&M associate professor Akhilesh Gaharwar and graduate student Patrick Lee are developing a new class of hydrogels that can leverage light for drugdelivery and regenerative medicine treatments. Credit: Texas A&M Engineering Hydrogels are commonly used inside the body to help in tissue regeneration and drugdelivery.
Cytonus Therapeutics Announces Publication in Nature Biomedical Engineering of Preclinical Results to Support Disease-Specific Drug-Delivery Capabilities of their Novel Cargocyte™ Platform Cytonus Therapeutics Announces Publication in Nature Biomedical Engineering of Preclinical Results to Support Disease-Specific Drug-Delivery Capabilities (..)
Nanoscale machinery has many uses, including drugdelivery, single-atom transistor technology, or memory storage. Credit: Credit: University of Warwick Nanoscale machinery has many uses, including drugdelivery, single-atom transistor technology, or memory storage.
Dill/NIST In a technique known as DNA origami, researchers fold long strands of DNA over and over again to construct a variety of tiny 3D structures, including miniature biosensors and drug-delivery containers.
The 3 rd Annual Blood-Brain Barrier Summit is dedicated to helping drug developers enhance drugdelivery across the Blood-Brain Barrier (BBB) to enable effective treatments for neurodegenerative diseases. New for this year we also explore the mechanisms of SARS-CoV-2 brain entry. DOWNLOAD THE PROGRAM HERE.
Researchers at ETH Zurich have developed a method for concentrating and releasing drugs in the brain with pinpoint accuracy. This could make it possible in the future to deliver psychiatric and cancer drugs and other medications only to those regions of the brain where this is medically desirable.
Sustainability for Injectable Delivery Devices. Connected DrugDelivery Devices. Eleanor Kimber, Principal Device Engineer, GSK. Markus Hemminger, Principal Medical Device Engineer, Roche. Petra Renne, Senior Expert Engineering, Novartis. Nima Aghajari, Senior Simulation Engineer, Sanofi.
Leading experts from big pharma will be presenting case studies on recent advances in platform approaches in drugdelivery devices and smart devices, while a panel discussion will explore the emerging opportunities of platforms for injectable devices. Who should attend: Drug-delivery developers. Medical Device Engineers.
Scientists have established a new method to image proteins that could lead to new discoveries in disease through biological tissue and cell analysis and the development of new biomaterials that can be used for the next generation of drugdelivery systems and medical devices.
Paul Roussel is currently a Senior Director of Combination Products at Kiniksa Pharmaceuticals in the CMC Technical Operations Group with over 20 years of experience in the drugdelivery and medical device space. in Plastics Engineering and M.S. in Manufacturing Engineering. He completed his B.S.
The Future of DrugDelivery and Combination Product Device Design. The pre-filled syringes industry is growing at an exponential rate with innovations in parenteral delivery device development to aid self-administration and deliver biologics, high concentration, and large-volume drug products.
An international team led by a Skoltech researcher has developed a method of fabrication for biodegradable polymer microcapsules, made more efficient by turning to an unusual source of inspiration – traditional Russian dumpling, or pelmeni, making. The two papers were published in Materials and Design and ACS Applied Materials and Interfaces.
SHL Medical is a world-leading solutions provider for advanced drugdelivery systems with a unified purpose to further enable patient independence. The team was already out there, so I agreed.”. Palmetto in North Charleston was the last one, and they did a fantastic presentation for us. It just felt right.
Uncover advances in CNS gene therapy , new generation vectors for intravenous delivery, and the challenges of scaling up for CNS delivery beyond highly specialized centers. The high concentration of scientists who face similar challenges makes this Summit so essential to the development of the field.
The Latest Innovations In Digital Health And On-Body DrugDelivery For The Pharmaceutical Industry. Who Should Attend: •Executives, Directors, VPs, Heads, Principals, Managers of: •Drug-Delivery Developers. Device Engineering. SAE Media Group’s 3rd Annual. Wearable Injectors and Connected Devices Conference.
In order to promote the use of exosomes in various therapeutic applications including targeted drugdelivery vehicles, engineered exosomes and many more, there are a number of companies that offer services related to the isolation, purification, characterization or quantification of exosomes. Our Social Media Platform.
Known as “two-dimensional electrolytes”, these smart materials could potentially be used in many things from drugdelivery to energy storage Credit: National University of Singapore Intelligent materials, the latest revolution in the field of materials science, can adapt their properties depending on changes in their surroundings.
– Before the huge potential of tiny nanocarriers for highly targeted drugdelivery and environmental clean-up can be realized, scientists first need to be able to see them. Credit: Washington State University PULLMAN, Wash.
Newly-published “contact lens technologies of the future” paper reviews innovative uses for disease detection and therapy, drugdelivery, vision enhancement and mor Credit: Centre for Ocular Research & Education (CORE) WATERLOO, Ontario, March 29, 2021–A newly-published paper represents one of the most comprehensive reviews of (..)
Louis have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation. The engineered cells reduced inflammation and prevented a type of damage to bone, known as bone erosion, in a mouse model of rheumatoid arthritis. Science Advances, Sept. 10.1126/sciadv.abj1414.
In 2021, 72% of newly approved drugs were small molecules, and almost 50% of new drugs approved were OSD. While the industry is seeing advances in alternative drugdelivery systems, oral solid doses, such as pills, capsules and soft gels, remain at the forefront of the industry.
Top of the list is the Verily Value Suite analytics platform – designed to help health systems deliver personalised patient care – and various early-stage programmes, including “remote patient monitoring for heart failure and micro needles for drugdelivery.”
The new master agreement, covering another five years, will foster research on genetic medicines, intrathecal delivery of therapeutics into the spinal canal or subarachnoid space of the brain, and the use of nanoparticles to improve drugdelivery.
For instance, drugdelivery devices may meet all technical requirements regarding dosage and delivery methods but fail in practical use by patients. This involves guiding through steps like design thinking, behavioral design, human factors and engineering, to make sure the process produces reliable, patient-informed evidence.
The growing demand for complex medical devices, including implants, surgical equipment, catheters, and other invasive devices, has prompted the medical device developers to innovate and introduce biocompatible, high-performance medical-device coatings that can meet the operational, clinical, and engineering requirements for these devices.
Evox Therapeutics is a privately held, Oxford -based biotechnology company focused on harnessing and engineering the natural delivery capabilities of extracellular vesicles, known as exosomes, to develop an entirely new class of therapeutics. ” About Evox Therapeutics. For further information visit: www.evoxtherapeutics.com.
In the last few years, researchers have become interested in using in vitro transcribed (IVT) mRNA as a drugdelivery agent. The IVT mRNAs are structurally similar to natural mRNAs, these synthetic mRNAs can be used to express proteins through genetic engineering.
The conference will explore advancements in ophthalmic treatments and variety of novel drugs, which are showing great clinical trial data. There will also be a specific focus on drugdelivery along with advancements in novel technologies.
Keeping the user experience at the forefront in the design of their insulin delivery device, experts at HTL-STREFA , a subsidiary of MTD Medical Technology and Devices SA, have engineered the world’s shortest and thinnest insulin needle. Known as Droplet Micron , the needle measures just 34 gauge by 3.5
16:36] If it is an interventional study, you get you get into things like randomization technologies, and IP delivery or drugdelivery, and drug tracking tools. [17:24] 9:47] Addressing redundancy between site and sponsor software solutions and sites taking control of their technology stack . [11:39]
Through our innovation in the scientific discovery of new potential drug targets, personalised healthcare, molecular engineering, biomarkers and continuous drugdelivery, we strive to design the right therapies for the right patients.
To purchase DermSafe: Just search for “DermSafe” in Amazon.ca’s search engine or click on www.amazon.ca/shops/dermsafe. The technology enhances the delivery of ingredients to and through the skin and is protected by patents in eleven countries. The product listing offered on Amazon.ca shops/dermsafe.
Conjugation with a Variety of Molecular Conjugates and Labels The combination of the conjugates / labels with molecules ( proteins, peptides, antibodies and small molecules ) is being used abundantly for several applications, ranging from therapeutics and diagnostics to isolation and characterization of drugdelivery systems.
.
Relying on independent research and development, the Company has formed gene recombination and fermentation engineering technology, and developed a number of core technologies, such as recombinant collagen, enzymatic and genetic engineering synthesis of bioactive peptides.
Xtalks spoke with WeiQi Lin, MD, PhD, executive vice president, research & development, and principal scientist at DURECT Corporation — a company focused on developing drugs and drugdelivery methods in therapeutic areas with significant unmet need — about her transition from academia to industry. Focus Fueling Pace.
Through our innovation in the scientific discovery of new potential drug targets, personalised healthcare, molecular engineering, biomarkers and continuous drugdelivery, we strive to design the right therapies for the right patients. Review by other regulatory authorities is ongoing.
We organize all of the trending information in your field so you don't have to. Join 21,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content